Adalimumab suppresses markers of structural damage in ankylosing spondylitis
Nature Clinical Practice Rheumatology 4, 622 (2008). Ver artigo completo2
Available therapeutic options following failure of a first anti-TNF agent
Nature Clinical Practice Rheumatology 5, 115 (2009). doi:10.1038/ncprheum1028 Alan J Silman Ver artigo completo
New NICE Guidelines To Help Thousands Of People With Rheumatoid Arthritis
Arthritis / Rheumatology News From Medical News Today Thousands of people with rheumatoid arthritis are set to benefit from a new guideline to be published this week. The National Institute for Health and Clinical Excellence (NICE) and the National Collaborating Centre for Chronic Conditions will issue a guideline to improve the management of rheumatoid arthritis in [...]
NICE guidelines on anti-tumor necrosis factor therapy for RA
David L Scott* and Sophia Steer The UK National Institute for Health and Clinical Excellence (NICE) utilizes the available evidence to provide guidance on the efficacy and cost-effectiveness of existing health technologies. NICE advisors decide that a technology is of value to society when its cost falls beneath a certain threshold—conventionally under £30,000 (approximately $50,000) per [...]